In contrast, ghrelin levels were normal in subgroups of patients in one study (39%) (Wolf et al, 2006) and all patients in another study (gastric and colorectal cancer, n=58) (Huang et al, 2007). This evidence concerns the gene GHRL and colorectal cancer.